G. R. Newkome et al.
FULL PAPER
3,5-Bis(2,2':6',2''-terpyridin-4'-yl)-1-bromobenzene (4): Bromo-bis(terpyr-
idine) ligand 4 was synthesized (35% overall yield) by same procedure as
for 3 by using 1-bromo-3,5-dicarboxaldehyde[34] as a starting material. M.p.
308 3098C; 1H NMR (CDCl3): d 7.41 (dd, J 6 Hz, 4H; H5, 5''), 7.94 (dd,
124.30, 124.51 ((6 3)-C3), 127.50(( 6 3)-C5), 127.70(( 6 3)-C2Ar),
130.26 (6-C3 3-C6Ar), 133.89 (6-C4 3-C5Ar), 138.03 ((6 3)-C4),
Ar
Ar
141.02 ((6 3)-C1Ar), 147.55, 148.39 ((6 3)-C4'), 152.46 ((6 3)-C6),
155.34, 155.60(( 6 3)-C2), 158.23 ((6 3)-C2') ppm; IR (KBr):nÄ 3112,
2923, 2856, 1606, 1547, 1467, 1429, 1405 cmÀ1; UV/Vis (MeCN): lmax 290
(1.13 Â 105), 310(1.20 Â 105), 490nm (4.70 Â 104); MALDI-TOF: m/z: 1837
[ÀPF6], 1692 [À2PF6], 1547 [À3PF6], calcd for C81H60N12Ru2P4F24 (1982);
elemental analysis (%): calcd (2H2O): C 48.16, H 3.17, N 8.32; found: C
48.14, H 3.54, N 8.52.
4
J 8 Hz, 4H; H4, 4''), 8.15 (s, 2H; H2, 6Ar), 8.30(s, 1H; H Ar), 8.73 (d, J
8 Hz, 4H; H3, 3''), 8.78 (d, J 5 Hz, 4H; H6, 6''), 8.81 (s, 4H; H3', 5') ppm;
13C NMR (CDCl3): d 119.23 (C3'), 121.62 (C3), 123.90(C 4Ar), 124.18 (C5),
125.23 (C1Ar), 130.96 (C2Ar), 137.12 (C4), 141.63 (C3Ar), 148.88 (C4'), 149.33
(C6), 156.10(C 2), 156.33 (C2'); ESI-MS: m/z: 620[ H ]; calcd for
C36H23N6Br (619); IR (KBr): nÄ 3050, 3012, 1585, 1567, 1469, 1385 cmÀ1
;
[(3)Ru2(6)2][PF6]4 (11): Route 2: Bis(terpyridine)ligand 3 (36 mg, 65 mmol)
was added to a suspension of mono(RuIII) adduct 8 (69 mg, 130 mmol),
following the above method B, to afford 11 as red microcrystals: yield:
100 mg (77%). This sample was spectrally identical to the sample obtained
by Route 1.
elemental analysis (%): calcd (1H2O): C 67.82, H 3.93, N 13.19; found: C
67.75, H 3.97, N 13.24.
[Ru2(3)Cl6] (5): Method A: Bis(terpyridine)ligand 3 (200 mg, 360 mmol)
was added to a solution of RuCl3 ¥ 3H2O (188 mg, 720 mmol) in EtOH
(20mL), then the suspension was refluxed for 12 h. After mixture had been
cooled, the resultant dark brown solid was filtered, washed with cold
EtOH, and dried in vacuo to yield the bis(RuIII) adduct 5 as a dark brown
solid: yield: 320mg (92%); m.p. > 4008C; IR (KBr): nÄ 3062, 2923, 2852,
1602, 1548, 1472, 1399 cmÀ1. This material was used without further
purification.
[Ru2(3)3][Cl]4 (12): Bis(terpyridine)ligand 3 (114 mg, 200 mmol) was added
to a suspension of the bis(RuIII) adduct 5 (97 mg, 100 mmol), following the
above method B, to yield the free bis(terpyridine)-terminated trimeric
precursor 12 as red microcrystals: yield: 180mg (89%); m.p. >4008C;
1H NMR (CD3OD): d 2.79(s, 3H; 5-CH3), 2.94(s, 6H; 3-CH3), 7.40 9.76
(m, aromatics and terpyridines, 69H) ppm; 13C NMR (CD3OD): d 20.89,
122.01, 122.60, 125.19, 125.69, 128.01, 130.54, 136.84, 138.51, 141.32, 148.76,
149.25, 152.40, 156.12, 158.97 ppm; IR (KBr): nÄ 3069, 2925, 2853, 1605,
1545, 1470, 1396 cmÀ1; UV/Vis (MeCN, PF6 counterion): lmax 288 (1.35 Â
105), 310(1.22 Â 105), 492 nm (5.0 Â 104); MALDI-TOF: m/z: 1864 [ÀCl4],
calcd for C111H78N18Ru2Cl4 (2006).
[Ru(6)Cl3] (8): 4'-(4-Methylphenyl)-2,2':6',2''-terpyridine[37] (6; 200 mg,
620 mmol) was treated with one equivalent of RuCl3 ¥ 3H2O (160mg,
620 mmol) in EtOH (20mL), as described in the above Method A, to give
the desired 8 as a brown solid: yield 290mg (87%); m.p. > 4008C; IR
(KBr): nÄ 3066, 3041, 2919, 2854, 1601, 1548, 1467, 1403 cmÀ1. This material
was used without further purification.
[Ru4(3)3][Cl]10 (13): Trimeric precursor 12 (50mg, 25 mmol) was added to a
solution of RuCl3 ¥ 3H2O (13 mg, 50 mmol) in EtOH (10mL), and the
suspension was refluxed for 12 h. After the mixture had been cooled, the
dark red solid was filtered, washed with cold EtOH and dried in vacuo to
yield 13 as a dark brown solid: yield: 45 mg (74%); m.p. >4008C; IR
(KBr): nÄ 3061, 2923, 2866, 1604, 1540, 1469, 1395 cmÀ1. This material was
used without further purification.
[Ru(6)2][PF6]2 (9): Method B: Mono(terpyridine)ligand
6 (61 mg,
188 mmol) was added to a suspension of mono(RuIII) adduct 8 (100 mg,
188 mmol) in MeOH (20mL), then N-ethylmorpholine (500 mL) was
added; the mixture was refluxed for 12 h. After the mixture had been
cooled, the resulting deep red solution was filtered through celite, then a
slight excess of methanolic ammonium hexafluorophosphate was added to
precipitate 9, which was filtered, sequentially washed with MeOH, Et2O,
and aqueous acetone, then dried in vacuo to afford red microcrystals: yield:
One-pot synthesis of [Ru6(3)6][PF6]12 (14): Bis(terpyridine)ligand
3
(114 mg, 200 mmol) was added to a suspension of the bis(RuIII) adduct 5
(190mg, 200 mmol), following the above method B, to give (85%) a dark
red solid, which was filtered, then purified by TLC (SiO2; eluent: aqueous
MeCN/saturated KNO3 solution (1:7:1)). The major dark band was
collected and extracted, then excess methanolic ammonium hexafluoro-
phosphate was added to precipitate 14, which was sequentially washed with
MeOH, Et2O, and aqueous acetone, and dried in vacuo to yield dark purple
microcrystals: yield: 160mg (43%); m.p. >4008C; Rf 0.55; 1H NMR
(CD3CN): d 2.93 (s, 3H; CH3), 7.31 (dd, 4H; H5, 5''), 7.62 (d, 4H; H6, 6''),
8.06 (dd, 4H; H4,4''), 8.41 (s, 2H; H4, 6Ar), 8.87 (d s, 5 H; H3, 3'' H2Ar), 9.37
(br, 4H; H3', 5') ppm; 13C NMR ([D6]DMSO): d 21.54 (CH3), 121.83 (C3'),
1
130mg (67%); m.p. >4008C; H NMR (CD3CN): d 2.74 (s, 3H; CH3),
7.37 (dd, 2H; H5, 5''), 7.62 (d, 2H; H6,6''), 7.78 (d, 2H; H3, 5Ar), 8.14 (dd, 2H;
H4, 4''), 8.31 (d, 2H; H2, 6Ar), 8.83 (d, 2H; H3, 3''), 9.19 (s, 2H; H3', 5') ppm;
13C NMR (CD3CN): d 21.91 (CH3), 122.83 (C3'), 125.94 (C3), 128.89 (C5),
129.14 (C2Ar), 131.77 (C3Ar), 135.39 (C4Ar), 139.47 (C4), 142.52 (C1Ar), 149.75
(C4'), 153.91 (C6), 156.88 (C2), 159.74 (C2') ppm; IR (KBr): 3086, 2924, 2854,
1607, 1550, 1479, 1428, 1407 cmÀ1; UV/Vis (MeCN): lmax 284 (5.89 Â 104),
310(6.60 Â 104), 486 nm (2.48 Â 104); MALDI-TOF: m/z: 892 [ÀPF6], 747
[À2PF6], calcd for C44H34N6RuP2F12 (1037); elemental analysis (%): calcd:
C 50.91, H 3.28, N 8.10; found: C 50.83, H 3.36, N 8.03.
4
124.62 (C5Ar), 125.09 (C3), 127.96 (C2Ar), 130.32 (C5), 137.60(C Ar), 138.24
[(6)Ru(7)][PF6]2 (10): Bromo-mono(terpyridine)ligand 7[38] (39 mg,
100 mmol) was added to suspension of mono(RuIII) adduct 8 (53 mg,
100 mmol), following the above method B, to afford 10 as red microcrystals:
yield: 95 mg (86%); m.p. >4008C; 1H NMR (CD3CN): d 2.56 (s, 3H; 6-
CH3), 7.19 (m, 4H; (6 7)-H5, 5''), 7.44 (dd, 4H; (6 7)-H6, 6''), 7.60(d, 2H;
6-H3, 5Ar), 7.96 (m, 6H; (6 7)-H4, 4 (7)-H2, 6Ar), 8.11 (d, 2H; 7-H3, 5Ar), 8.66
(d, 4H; (6 7)-H3, 3''), 8.99 (s, 2H; 7-H3', 5'), 9.00 (s, 2H; 6-H3', 5') ppm;
13C NMR (CD3CN): d 21.22 (6-CH3), 122.15 (7-C3'), 122.29 (6-C3'), 125.29
((6 7)-C3), 128.20( 7-C5), 128.30( 6-C5), 128.45 (7-C3Ar), 130.43 (6-C2Ar),
131.08 (7-C2Ar), 133.48 (6-C3Ar), 134.68 (7-C1Ar), 136.85 ((6 7)-C4Ar),
138.83 ((6 7)-C4), 141.84 (6-C1Ar), 147.74 (7-C4'), 149.20( 6-C4'), 153.22
((6 7)-C6), 156.10( 7-C2), 156.38 (6-C2), 158.90( 7-C2'), 159.90( 6-C2') ppm;
IR (KBr): nÄ 3085, 2925, 2862, 1608, 1545, 1467, 1430, 1408 cmÀ1; UV/Vis
(MeCN): lmax 286 (5.60 Â 104), 310(5.97 Â 104), 490nm (2.38 Â 104); ESI
MS: m/z: 40 6 z( 2, without counter ion) calcd for C43H31N6BrRuP2F12
(1102); elemental analysis (%): calcd: C 46.82, H 2.77, N 7.62; found: C
46.72, H 2.82, N 7.52.
(C4), 140.10 (C1Ar), 146.86 (C4'), 152.24 (C6), 155.25 (C2), 158.14 (C2') ppm;
IR (KBr):nÄ 3074, 2922, 2854, 1603, 1532, 1469, 1394 cmÀ1; UV/Vis
(MeCN): lmax 290(3.22 Â 105), 312 (3.37 Â 105), 496 nm (1.43 Â 105);
MALDI-TOF: m/z: 5544 [À1PF5], 5400 [À1PF6–1PF5], 5292[À3PF5],
5166[À4PF5], 5020[À4PF5–1PF6], calcd for C222H156N36Ru6P12F72 (5670);
elemental analysis (%)(8H2O): calcd: C 45.82, H 2.96, N 8.67; found: C
45.86, H 2.98, N 8.68.
Stepwise synthesis of [Ru6(3)6][PF6]12 (14): Trimeric precursor 12 (33 mg,
17 mmol) was added to a suspension of the bis(RuIII) adduct 13 (40mg,
17 mmol) in MeOH (20mL), then N-ethylmorpholine (500 mL) was added
and the mixture was refluxed for 12 h. The work-up afforded (ca. 80%)
crude hexamer (chloride counterions), which was subjected to the above
and purification processes (method B): yield: 40mg (55% overall); the
sample was identical in all respects to the above.
[(3)3Ru6(4)3][PF6]12 (16): Bromo-bis(terpyridine)ligand 4 (43 mg, 70 mmol)
was added to bis(RuIII) adduct 5 (68 mg, 70 mmol), following the above
method B, to give (ca. 85%) a dark red solid, which was filtered, then
purified with TLC (SiO2; eluent: aqueous MeCN/saturated KNO3 solution
(1:7:1)). The major dark band was collected and extracted, then excess
methanolic ammonium hexafluorophosphate was added to precipitate 17,
which was sequentially washed with MeOH, Et2O, and aqueous acetone,
and dried in vacuo to yield dark purple microcrystals: yield: 50mg (36%);
[(3)Ru2(6)2][PF6]4 (11): Route 1: Mono(terpyridine)ligand
206 mmol) was added to suspension of bis(RuIII
adduct
6
5
(67 mg,
(100 mg,
)
103 mmol), following the above method B, to yield 11 as red microcrystals:
1
yield: 130mg (65%); m.p. 230 8C; H NMR (CD3CN): d 2.68 (s, 6H; 6-
CH3), 2.96 (s, 3H; 3-CH3), 7.35 (dd, 8H; (6 3)-H5, 5''), 7.62 (m, 8H; (6 3)-
H6, 6''), 7.74 (d, 4H; 6-H3, 5Ar), 8.12 (m, 8H; (6 3)-H4, 4''], 8.28 (d, 4H; 6-
H2, 6), 8.49 (s, 2H; 3-H4, 6Ar), 8.82 (d, 4H; 6-H3, 3''Ar), 8.92 (d s, 5 H; 3-
H3, 3'' H2Ar), 9.17 (s, 4H; 6-H3', 5'), 9.40(s, 4H; 3-H3', 5') ppm; 13C NMR
(CD3CN): d 20.41, 20.77 ((6 3)-CH3), 121.35, 121.83 ((6 3)-C3'),
1
m.p. >4008C; Rf 0.60; H NMR (CD3CN): d 2.90(s, 3H; 3-CH3), 7.30
(m, 8H; (3 4)-H5, 5''), 7.60(d, 8H; ( 3 4)-H6, 6''), 8.05 (dd, 8H; (3 4)-
H4,4''), 8.41 (s, 2H; 3-H4, 6Ar), 8.75 (s, 2H; 4-H2, 6Ar), 8.85 (d s, 9 H; (3 4)-
2952
¹ WILEY-VCH Verlag GmbH, 69451 Weinheim, Germany, 2002
0947-6539/02/0813-2952 $ 20.00+.50/0
Chem. Eur. J. 2002, 8, No. 13